Mr. Bill Thomas reports

NETWORK ONCOLOGY INC. ANNOUNCES NAME CHANGE AND CONSOLIDATION

Network Oncology Inc. has changed its name to Network Life Sciences Inc. The name change has been effected pursuant to the company's recently announced acquisition of the Ebola testing technology and reflects its diversification to disease testing products in addition to its current oncology generics business model. The company further announces that it intends to consolidate its issued and outstanding shares on the basis of one (new) postconsolidation share for each three (old) preconsolidation shares. The shares will commence trading under the new name and on a consolidated basis on June 23, 2015, under the same symbol NOI. The record date for the share consolidation is June 25, 2015. The company currently has 80,509,232 common shares issued and outstanding. Following the consolidation, it is anticipated that the company will have approximately 26,836,410 common shares issued and outstanding.

The exercise or conversion price, and the number of common shares issuable under any of the company's outstanding warrants will be proportionately adjusted to reflect the consolidation in accordance with their respective terms thereof. No fractional common shares will be issued pursuant to the consolidation, and any fractional common shares that would otherwise be issued will be rounded down to the nearest whole number.

We seek Safe Harbor.